Regulatory Opportunities and Challenges in Osteoporosis
Date: August 29, 2011
Join Theresa Kehoe, M.D. of the US Food and Drug Administration and Javier San Martin, M.D., from Amgen, Inc. as they discuss regulatory opportunities and challenges in osteoporosis on Friday, September 16 from 11:00am-12:00pm in Room 20BCD.. Dr. Kehoe will present the FDA perspective, FDA priorities and overall directions and Dr. San Martin will provide industry perspective. Following the presentations, a panel discussion will be moderated by Gayle Lester, Ph.D., National Institute of Arthritis and Musculoskeletal and Skin Diseases.